We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

136 hedge funds and large institutions have $338M invested in Sanofi Contingent Value Rights in 2013 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 21 increasing their positions, 35 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% more capital invested

Capital invested by funds: $324M → $338M (+$13.8M)

7% less funds holding

Funds holding: 146 → 136 (-10)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

40% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 35

59% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 17

Holders
136
Holders Change
-10
Holders Change %
-6.85%
% of All Funds
4.41%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.13%
New
7
Increased
21
Reduced
35
Closed
17
Calls
$1.01M
Puts
–
Net Calls
+$1.01M
Net Calls Change
+$1.01M

Top Buyers

Rank Fund Capital Flow
1
FTCM
Fir Tree Capital Management
New York
+$6.72M
2
MCM
Mason Capital Management
New York
+$5.99M
3
WA
Whitebox Advisors
Minnesota
+$2.25M
4
DI
Dalton Investments
Nevada
+$1.24M
5
SC
Sophrosyne Capital
New York
+$1.09M

Top Sellers

Rank Fund Capital Flow
1
TCA
Taconic Capital Advisors
New York
-$5.79M
2
RCM
Royal Capital Management
New York
-$3.55M
3
FCM
Farallon Capital Management
California
-$2.51M
4
BlackRock
BlackRock
New York
-$2.27M
5
PCM
Pentwater Capital Management
Florida
-$1.69M
Name Holding Trade Value Shares
Change 		Change in
Stake
WT
101
Whittier Trust
California
$5K – – –
Royal Bank of Canada
102
Royal Bank of Canada
Ontario, Canada
$5K +$27 +14 +0.6%
NEAM
103
New England Asset Management
Connecticut
$4K – – –
First Eagle Investment Management
104
First Eagle Investment Management
New York
$3K – – –
MWP
105
MYCIO Wealth Partners
Pennsylvania
$3K – – –
AIG
106
American International Group
New York
$2.65K – – –
Fifth Third Bancorp
107
Fifth Third Bancorp
Ohio
$2K – – –
MCM
108
Manchester Capital Management
Vermont
$2K – – –
TCOV
109
Trust Company of Vermont
Vermont
$2K – – –
WA
110
WealthTrust-Arizona
Arizona
$2K – – –
EWM
111
Elite Wealth Management
Washington
$2K +$1.92K +1,008 New
Bank of Montreal
112
Bank of Montreal
Ontario, Canada
$1K -$381 -200 -28%
DADC
113
D.A. Davidson & Co
Montana
$1K – – –
DAC
114
Dividend Assets Capital
South Carolina
$1K – – –
EWM
115
Evercore Wealth Management
New York
$1K – – –
FFC
116
First Financial Corp
Indiana
$1K – – –
HI
117
Hudock Inc
Pennsylvania
$1K – – –
NES
118
New England Securities
New York
$1K – – –
PSUF
119
People's United Financial
Connecticut
$1K – – –
SNT
120
Security National Trust
West Virginia
$1K – – –
OIA
121
Optimum Investment Advisors
Illinois
$1K +$952 +500 New
ECM
122
Estabrook Capital Management
New York
$28 – – –
Manulife (Manufacturers Life Insurance)
123
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$19 – – –
TCA
124
Taconic Capital Advisors
New York
– -$5.79M -3,000,000 Closed
RCM
125
Royal Capital Management
New York
– -$3.55M -1,870,269 Closed
2 3 4
5
6

GCVRZ Hedge Fund Activity: Q3 2013 in Review

136 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q3 2013, worth a combined $338M — up 4.3% from $324M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of GCVRZ and 7 opened new positions — a net loss of 10 holders — while 35 trimmed existing stakes and 21 added.

The largest buyer was Fir Tree Capital Management, adding an estimated $6.72M. The largest seller was Taconic Capital Advisors, exiting entirely with an estimated $5.79M sold.

  • 136 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q3 2013, down from 146 in Q2 2013.
  • Funds reported $338M of Sanofi Contingent Value Rights stock for Q3 2013, up 4.3% quarter-over-quarter.
  • 7 funds opened new Sanofi Contingent Value Rights positions in Q3 2013 and 17 closed out, a net change of -10 holders.
  • The largest Sanofi Contingent Value Rights buyer in Q3 2013 was Fir Tree Capital Management, an estimated $6.72M added.
  • The largest Sanofi Contingent Value Rights seller in Q3 2013 was Taconic Capital Advisors, an estimated $5.79M sold.

Based on aggregated 13F filings for Q3 2013.